Literature DB >> 9924579

Tuberculous meningitis and co-infection with HIV.

J M Topley1, S Bamber, H M Coovadia, P D Corr.   

Abstract

The clinical, laboratory and radiological features of 30 children with clinically diagnosed tuberculous meningitis (TBM) who were HIV-seronegative were compared with those of ten HIV-infected children with TBM. Such comparative data are not currently available in the literature and so are an important addition to our knowledge of the HIV-TB co-infection epidemic. In comparison with the HIV-negative children, those infected with HIV were younger, had a shorter duration of symptoms and were more often Mantoux-negative (HIV-positive 23% vs HIV-negative 70%; p = 0.01). On presentation, all children in both groups were in MRC TBM stages II or III. Clinical features were similar in both groups but computed tomography of the brain showed more ventricular enlargement (HIV-positive 80% vs HIV-negative 63%), gyral enhancement (HIV-positive 60% vs HIV-negative 17%; p = 0.01) and cerebral atrophy (HIV-positive 40% vs HIV-negative 17%). Outcome was considerably worse in the HIV-positive children, of whom 30% died (vs HIV-negative 0/30; p = 0.01) and the remainder were moderately (HIV-positive 30% vs HIV-negative 24%) or severely (HIV-positive 30% vs HIV-negative 19%) handicapped at the end of treatment. While clinical features were not markedly different in HIV-infected and uninfected children with TBM, abnormal radiological findings were more common in the HIV-infected group and outcome was considerably worse. Co-existing HIV encephalopathy and diminished immune competence undoubtedly contributed to the more severe clinical and neuro-radiological features.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924579     DOI: 10.1080/02724936.1998.11747957

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  6 in total

1.  MRI findings in children with tuberculous meningitis: a comparison of HIV-infected and non-infected patients.

Authors:  Gerrit Dekker; Savvas Andronikou; Ronald van Toorn; Shaun Scheepers; Andrew Brandt; Christelle Ackermann
Journal:  Childs Nerv Syst       Date:  2011-04-15       Impact factor: 1.475

2.  Tuberculous meningitis and HIV.

Authors:  Sunil Karande; Vishal Gupta; Madhuri Kulkarni; Anagha Joshi; Mhisti Rele
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

3.  Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis.

Authors:  Liana Tsenova; Bande Mangaliso; George Muller; Yong Chen; Victoria H Freedman; David Stirling; Gilla Kaplan
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 4.  Biomarkers of Tuberculous Meningitis and Pediatric Human Immunodeficiency Virus on the African Continent.

Authors:  Charlotte Elisabeth Teunissen; Ursula Rohlwink; Dasja Pajkrt; Petrus J W Naudé
Journal:  Front Neurol       Date:  2022-05-19       Impact factor: 4.086

Review 5.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Brainstem ischemic lesions on MRI in children with tuberculous meningitis: with diffusion weighted confirmation.

Authors:  Dirk Johannes van der Merwe; Savvas Andronikou; Ronald Van Toorn; Manana Pienaar
Journal:  Childs Nerv Syst       Date:  2009-05-08       Impact factor: 1.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.